FINWIRES · TerminalLIVE
FINWIRES

CSL, Plasma Industry Could Continue to Grow Strongly for Considerable Period, Jefferies Says

By

CSL (ASX:CSL) and the plasma industry could continue to grow strongly for a considerable period, Jefferies said in a Thursday note.

The plasma industry is treating at most 34% of the total potential patients that it could in the US and European Union markets. CSL's immunoglobulin franchise accounts for 38% of its fiscal year 2026 group revenue estimate of AU$15.11 billion.

Despite potential competitor entry into the autoimmune myositis market, any potential future competitor approvals in dermatomyositis and immune-mediated necrotizing myopathy are not seen as having a material effect on immunoglobulin volumes.

Immunoglobulin is considered a second-line therapy in autoimmune myositis. 4% of the volume of immunoglobulin used in Australia is for autoimmune myositis, according to the Australian National Blood Authority data.

The investment firm has a hold rating on CSL and a price target of AU$108 per share.

Related Articles

Asia

Lopal Tech Says No Undisclosed Matters That Would Warrant Unusual Movement in Stock Price

Jiangsu Lopal Tech. Group (SHA:603906, HKG:2465) said there were no undisclosed matters that would warrant an unusual movement in its stock's price, according to a Hong Kong bourse filing Wednesday.Shares of the automotive specialty chemicals seller were down nearly 6% in Thursday late morning trade.On Wednesday, its shares rose 2% at close, snapping a three-day streak of losses.

HKG:2465SHA:603906
Asia

Hong Kong's H1 IPO Proceeds Hit Five-Year High, EY Says

Ernst & Young expects 84 initial public offerings in Hong Kong during the first half of 2026, raising a combined HK$209.8 billion, a five-year high, the audit firm said in its Chinese mainland and Hong Kong IPO report released Wednesday.The company noted a 100% increase in the number of IPOs and a 92% jump in funds raised in H1 2026 from the same period last year.A-share firms remained a key driver of the Hong Kong IPO market, with 121 mainland-listed companies applying for Hong Kong listings as of June 23.Industrial and technology companies accounted for 65% of IPO deals and 74% of total proceeds. These sectors mostly comprise segments such as AI large models and semiconductor chips, according to the report.

Hang Seng
Asia

Samsung Electronics Denies Rumors of KRW90 Trillion Share Buyback Plan; Shares Rise 5%

Samsung Electronics (KRX:005930) denied media rumors of the company planning to repurchase 90 trillion won worth of shares over a period of three years, beginning in July, according to a Thursday filing with the Korea Exchange.Denying the report published by Munhwa Ilbo in a Wednesday news report, Samsung Electronics said that although it was reviewing a share repurchase plan for stock-based compensation based on its 2026 management performance, no key matters, including the schedule or scale of the repurchase, had been finalized.Shares of the company rose nearly 5% in recent trade.

KRX:005930